This allowed us to group the tumor samples into molecular subtypes defined as: luminal (ER+ and/or PR+, ± HER2 but not amplified levels), HER2 (HER2 amplified), and TNBC (ER–, PR–, HER2–). The gene discussed is PGR; the disease is neoplasm.